According to a recent study that compares two drugs approved by the FDA for the treatment of osteoporosis, a clear winner has emerged. The study, involving 51 patients who used denosumab (Prolia) and 56 who used zoledronate (Reclast), showed that Prolia was significantly more effective in increasing spinal bone mineral density and produced fewer side effects than Reclast. Prolia, which works to prevent the breakdown of bone, is administered in 60-mg. doses twice a year. Reclast is more potent and is administered intravenously (5-mg.) once a year. Both drugs are effective in preventing fractures, and larger studies may be needed before prescribing physicians and their patients make any definitive decisions about preferring one over the other.
According to the study mentioned above, 29% of the Reclast patients experienced flu-like symptoms that lasted only a few days; none of the Prolia patients reported the same symptoms.
At Med-Fast Pharmacy, our pharmacists can assist you with all of your medication needs. We carefully monitor all the medications that you are taking to prevent possible harmful interactions, one of the reasons it is very important to get all your medications from one location. Our focus is to provide top notch medication management and support services essential in promoting positive health outcomes. We’re more than a Pharmacy, We’re Family!
